pharmacie et médicaments – Obstacles à l'accès aux buprénorphines à action prolongée (BAP)

This written question asks about obstacles to accessing long-acting buprenorphine medicines in France. These medicines are used for treating opioid dependence. The question seeks to understand why patients may face difficulties in obtaining these treatments and what can be done to improve access for those who need them.